v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating Expenses [Abstract]        
Research and development (including related party amounts of $13, $27, $26, and $50, respectively) $ 21,925 $ 17,861 $ 41,237 $ 34,914
General and administrative 4,965 4,949 10,083 10,068
Total operating expenses 26,890 22,810 51,320 44,982
Loss from operations (26,890) (22,810) (51,320) (44,982)
Other income, net:        
Interest income 1,886 1,561 2,798 3,425
Other (expense) income, net (1) (5) 1 (8)
Total other income , net 1,885 1,556 2,799 3,417
Net loss $ (25,005) $ (21,254) $ (48,521) $ (41,565)
Net loss per share - basic $ (0.63) $ (0.87) $ (1.51) $ (1.71)
Net loss per share - diluted $ (0.63) $ (0.87) $ (1.51) $ (1.71)
Weighted average common shares outstanding - basic 39,413,236 24,378,823 32,086,532 24,360,502
Weighted average common shares outstanding - diluted 39,413,236 24,378,823 32,086,532 24,360,502
Net loss $ (25,005) $ (21,254) $ (48,521) $ (41,565)
Other comprehensive (loss) income:        
Unrealized (loss) gain on investments, net (3) 2 (124) 131
Comprehensive loss $ (25,008) $ (21,252) $ (48,645) $ (41,434)